Biosensors International Group, Ltd.
- Home
- Companies
- Biosensors International Group, Ltd.
- Products
- BioMatrix Alpha - Model Biolimus A9 - ...
BioMatrix Alpha - Model Biolimus A9 -Proven Safety of the Biolimus Drug
BioMatrix™ Alpha presents the best in class stent platform design with unique pro-healing coating from the pioneer in abluminal biodegradable technology. It combines the proven safety of a DES with an abluminal biodegradable polymer, the proven efficacy of BA9™ and an innovative cobalt-chromium stent platform design.
Most popular related searches
cobalt chromium stent
stent system
drug carrier
stent design
drug release system
drug release
coronary stent
drug target
healing improvement
drug exposure
Abluminal coating absorbed after 6 to 9 months No drug carrier or drug inside the stent
- Early BMS-like endothelial coverage
- More targeted drug release
- Reduced systemic exposure
BA9™ Designed Specifically for Coronary Stent Application;
- Unique drug and proprietary of Biosensors International Group, Ltd.
- Designed for properties that would support healing and re-endothelialization
- Chemical characteristics allow:
- delivered with synchronous absorption of proprietary PLA polymer
- with no loss to the systemic system.